Arkolith/Insider Trading/TXMD/Form 4

Collins Cooper C.

DirectorTherapeuticsMD, Inc. (TXMD) · full profile →Form 4 · filed Aug 26, 2024
Net Buying
Open-Market Buys
$7K
Open-Market Sells
$0
Net Open-Market Flow
$7K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 22, 2024Buy(P)4K$1.73$7K52K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-24-002363) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML